Related Experiment Videos
Bone microarchitecture as an important determinant of bone strength
L Dalle Carbonare1, S Giannini
1Department of Medical and Surgical Sciences, Medical Clinic I, University of Padova, Padova, Italy. luca.dallecarbonare@unipd.it
Journal of Endocrinological Investigation
|April 1, 2004
Summary
Bone microarchitecture significantly impacts bone strength and fragility, independent of density. Treatments like bisphosphonates and parathyroid hormone can improve bone structure, offering insights into fracture prevention.
Area of Science:
- Biomedical Engineering
- Orthopedics
- Radiology
Background:
- Bone strength is determined by structure and microarchitecture.
- Cortical bone strength depends on width and porosity.
- Trabecular bone strength relies on shape, width, connectivity, and anisotropy.
Purpose of the Study:
- To review methods for assessing bone architecture.
- To explore the clinical significance of bone microarchitecture.
- To understand the impact of treatments on bone microarchitecture.
Main Methods:
- Two-dimensional analysis using optical microscopy and quantitative histology.
- Three-dimensional imaging and analysis using computed tomography and magnetic resonance.
- In vivo studies on animals and humans to assess treatment effects.
Main Results:
- Bone microarchitecture is a key determinant of bone fragility, independent of bone density.
- Glucocorticoid-induced osteoporosis and bone alterations in transplant patients can be identified through microarchitecture analysis.
- Bisphosphonates and parathyroid hormone demonstrated potential to preserve or improve bone microarchitecture.
Conclusions:
- Bone microarchitecture is crucial for understanding bone fragility and the efficacy of anti-osteoporotic drugs.
- Current in vivo methods for evaluating bone quality require further advancement in resolution and accuracy.